GETERO gemcitabine (as hydrochloride) 200 mg powder for injection vial

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

gemcitabine hydrochloride, Quantity: 228 mg

Tillgänglig från:

Hetero Australia Pty Ltd

INN (International namn):

Gemcitabine hydrochloride

Läkemedelsform:

Injection, powder for

Sammansättning:

Excipient Ingredients: sodium acetate trihydrate; sodium hydroxide; mannitol

Administreringssätt:

Intravenous Infusion

Enheter i paketet:

1 vial

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is also indicated for patients with 5-FU refractory pancreatic cancer.,Gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.,Gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

Produktsammanfattning:

Visual Identification: White to off-white lyophilised powder to be reconstituted for intravenous use.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Bemyndigande status:

Licence status A

Tillstånd datum:

2015-03-03